Home›People›Lakhmir Chawla
LC

Lakhmir Chawla

Founder, Chairman, & CMO at Platform Therapeutics. Also a director at ExThera Medical.

ExecutiveDirectorRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Aug 27, 2026·Suggest an edit

About Lakhmir Chawla

Lakhmir Chawla is a founder, chairman, & CMO at Platform Therapeutics.

Form D filings also name Lakhmir Chawla as a director at ExThera Medical.

Lakhmir Chawla first appears on SEC filings in 2021.

Experience

This experience comes from Lakhmir Chawla's profile and from SEC filings. For roles taken from filings, the years are when the filings name Lakhmir Chawla in the role, so the role may have started earlier or lasted longer.

Revelation Biosciences Inc. Current
Board Member
2023 – Present
Platform Therapeutics, Inc. Current
Founder, Chairman, & CMO
Co-Founder (2022 – Present)
2022 – Present · Andover, MA
Develops treatments for patients affected by chemotherapy toxicity and dialysis-related muscle cramps.
ExThera Medical Corp Current
Chief Medical Officer (2024 – Present)
Director
2021 – Present · Martinez, CA
University of California San Diego Current
Clinical Professor of Medicine
2017 – Present
Stavro Medical
Chief Executive Officer and Founder
2023 – 2024
Silver Creek Pharmaceuticals
Chair, Scientific Advisory Board
2020 – 2024
CalciMedica Inc
Board Member
2018 – 2023
Lowell Therapeutics, Inc.
Co-Founder; Chairman, Scientific Advisory Board
2020 – 2022
La Jolla Pharmaceutical Company
Chief Medical Officer
2015 – 2020
The George Washington University
Professor of Medicine
2015 – 2018
Washington DC Veteran Affairs Medical Center
Chief, Division of Intensive Care Medicine
2014 – 2015
Clinical Journal of the American a Society of Nephrology
Associate Editor
2011 – 2015
Kids Against Hunger DC Metro
Co Founder
2010 – 2015
George Washington University
Associate Professor of Medicine
2006 – 2015
The GW Medical Faculty Associates
Nephrologist
2002 – 2014

Key Colleagues at Startups

The people Lakhmir Chawla works with at each company, as listed on that company's latest Form D.

Platform Therapeutics, Inc. · Form D, Aug 27, 2026
JW
James Wilkie
Founder & CEO, director
ExThera Medical Corp · Form D, Sep 5, 2024
MD
Michael DiMeo
Executive officer
EB
Erin Borger
Chief Executive Officer and director
JP
John Preston
Director
RW
Robert Ward
Executive officer and director

Sources

  1. SECPlatform Therapeutics, Inc. Form D, filed Aug 27, 2026
  2. SECExThera Medical Corp Form D, filed Sep 5, 2024